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The Electrocardiogram 
In the entire realm of his work, Dr Josephson’s greatest love was 
the simple electrocardiogram (ECG). His discernment, based on 
the ECG, into the patient’s history and disease processes was 
legendary. Among the more important and insightful contributions 
he made to our understanding of heart disease and arrhythmias 
from the ECG are: observations of alternating preexcitation patterns 
in patients with Wolff-Parkinson-White (WPW) pattern who had more 
than one accessory atrioventricular (AV) accessory pathway (AP),1 
and a patient with 1:2 conduction AV using an AV pathway;2 the 
nature of electrocardiographic ‘left atrial enlargement’;3 multiple ECG 
manifestations of ventricular tachycardia (VT) in the same patient;4,5 
use of the 12-lead ECG to localise exit sites of post-infarction VT6,7 and 
premature ventricular complexes;8 studies on electrical alternans in 
wide complex tachycardias;9 a highly useful method of distinguishing 
VT from supraventricular tachycardia (SVT) with aberration in left 
bundle branch block (LBBB) wide-QRS tachycardias;10 variations in 
the ECG expression of atrial flutter;11 differentiation of insertion sites 
of atriofascicular pathways;12 classification of which portion of which 
coronary artery was affected in myocardial infarction;13,14 features of 
the ECG in what appears to be right ventricular outflow tract ectopy 
and VT that correlate with difficult catheter ablation;15 distinction of 
the causes of T-wave inversion (post-pacing cardiac memory versus 
ischaemia),16 and whether LBBB was new or old (with implications for 
patients with chest pain and LBBB on ECG).17
Throughout his career, Dr Josephson gave courses on ECG 
interpretation with his close friend Prof Hein Wellens; most EP fellows 
of the last 25 years have attended these legendary courses and come 
away with a new appreciation of this old tool and how much 
information can be extracted by masters such as Josephson and 
Wellens. In the later years of his career, he was invited along with Prof 
Wellens to provide a regular contribution to the prestigious journal 
Heart Rhythm – ‘Josephson and Wellens’ ECG Lessons: A Monthly Visit 
to the 12-Lead ECG’. Here, they retrieved some of the choice jewels 
from their treasures of ECGs obtained over the prior half-century, 
sharing their insights into how the ECG could yield important and 
often surprising information about the patient and their proper 
diagnosis and management. These pearls bear careful reading by the 
serious student of electrophysiology. Josephson was often heard to 
state something like the following: “The ECG never lies, but it doesn’t 
always tell you all it knows.”
A couple of anecdotes are worth sharing here. In preparing our 1988 
paper on correlation of the 12-lead ECG with ‘site of origin’ of VT, some 
of the ECGs had been recorded as a long continuous strip from which 
I had to cut several complexes of individual leads and affix them to 
paper in a standard 12-lead ECG format. In one case, I had inadvertently 
mounted a lead V5 upside down; as I was reviewing a stack of these 
ECGs with Dr Josephson, he immediately noted the error. I was of 
course very embarrassed and apologetic but he was not as bothered 
by it as I was, knowing what it should look like. He could also name 
from which patient most of the ECGs came. In another instance, 
during a regular Monday ECG conference in a darkened room, a fellow 
was squirming uncomfortably at the front of the room trying to 
analyse an ECG projected on the screen that showed an atrial 
bradycardia, incomplete right bundle branch block and mild right 
ventricular hypertrophy. At that moment, Dr Josephson burst into the 
room looking for one of the other fellows; he glanced at the ECG on 
the screen and blurted out the diagnosis (sinus venosus atrial septal 
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defect) and the name of the patient (one of his). Such was his 
command of the ECG. Although most cardiologists interpret the ECG 
well, and some even interpret it expertly, Dr Josephson interpreted 
and understood the ECG deeply, as do but a few others.
Supraventricular Arrhythmias 
Dr Josephson started his investigative career with supraventricular 
arrhythmias such as SVT and atrial fibrillation (AF) and flutter. In a 
general overview on paroxysmal SVT18 – on which he was the sole 
author – he showed even this early in his career (1978) how extensive 
his understanding of this family of arrhythmias was (as well as how 
much was still unknown). Among his favourite arrhythmias was AV 
nodal reentrant tachycardia (AVNRT), on which he published 
extensively throughout his career. The first of these studies investigated 
whether the atrium was a necessary component in AV nodal reentry.19 
Following this were investigations into upper and lower common 
pathways between the tachycardia circuit and atrium (above) and His 
bundle (below);20,21 using the ∆HA interval (HA during SVT versus HA 
during ventricular pacing at the SVT rate) to distinguish AV nodal 
reentry from orthodromic SVT using a septal AP;22 variations in 
retrograde conduction pathways in AVNRT, in which he showed that 
retrograde conduction did not necessarily have the same atrial 
activation pattern during SVT and retrograde conduction with 
ventricular pacing;23,24 the origin of accelerated junctional rhythm 
during slow pathway ablation for AVNRT;25 that standard slow pathway 
ablation of AVNRT suffices in patients with earliest retrograde 
activation in the coronary sinus;26 the unusual rhythm disturbance of 
1:2 AV conduction during sinus rhythm coexisting with typical AV 
nodal reentry (which many thought impossible);27 and his final major 
work on AVNRT, in which he matter-of-factly corrected some of his 
own prior work in the light of newer evidence.28 Dr Josephson also 
added to knowledge and practice in a paper on selection of sites for 
ablation of APs in WPW, in particular using the unipolar electrogram;29 
the previously-noted atriofascicular AP insertion study;12 and several 
papers investigating AF. These included evaluating the success of AF 
ablation by pulmonary vein (PV) isolation when entrance block into, 
and exit block out of, the PV were obtained,30,31 as well as correlating 
acute PV reconnection after ablation with poorer outcomes;32 a case 
in which AF was contained within a PV after isolation;33 and pointing 
out the frequency of aortic wall injury during AF ablation procedures.34 
From the start of his career to its end, despite his plethora of other 
investigative interests, his attention was never very far from SVTs.
 
Ventricular Tachycardia 
The area of clinical investigation for which Dr Josephson is most 
renowned is VT. In the 1970s, post-infarction VT was a major problem 
without a good solution. Antiarrhythmic drugs were palliative at best, 
and neither catheter ablation nor implantable defibrillators had been 
developed. Dr Josephson believed that effective treatment might hinge 
on a better understanding of the nature of the arrhythmia – which at that 
time was poor. He and his colleagues began a series of investigations 
that not only changed many aspects of the care of patients with VT, but 
eventually those with many other types of arrhythmias (to which the 
principles learned in VT investigation could be applied). The first studies 
he published in this area were an astounding series of four landmark 
papers, appearing in Circulation over a span of 13 months.4,35–37 This was 
a planned series (the first is entitled ‘Recurrent Sustained Ventricular 
Tachycardia. 1. Mechanisms’) setting forth the state of the art at that 
time, and showing that:
• VT in this setting was due to reentry; 
• Reentry occurred on the endocardium; 
• Reentry did not involve the proximal His-Purkinje system; and 
• Reentry occurred in a relatively small area. 
Figure 1: Diagram Showing How Recordings are Made 
Pre- and Post-left Ventricular Endocardial Resection for 
Treatment of Ventricular Tachycardia
At left, the left ventricle is shown opened at the time of surgery. A stylised ventricular 
tachycardia (VT) circuit is shown; a 4 x 5 electrode array records electrograms during VT as well 
as sinus rhythm immediately prior to resection of 2–3 mm of endocardium in a region where 
the VT has been mapped. Centre, the resection has been accomplished, removing endocardial 
layers along with some of the VT circuit. At right, the electrode array is positioned as before, 
but now recording from tissue deep to where the endocardium had been removed.
Figure 2: Recordings from 20-bipolar Electrode Array 
As shown in Figure 1. A: During ventricular tachycardia (VT), diastole is shaded yellow; green 
arrows denote diastolic potentials during VT. B: Recorded during sinus rhythm immediately 
prior to endocardial resection, blue arrows point to split potentials and red arrows to late 
potentials (recorded after the end of the QRS complex [dashed red line]). These split and late 
potentials correspond in size and morphology to the diastolic potentials during VT in the same 
recording electrodes. C: after endocardial resection, split and late potentials are gone (removed 
with specimen) and electrograms recorded during the QRS complex are much larger than 
before after removal of interposed scar. A 1 mV calibration signal is at right. SR = sinus rhythm.
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These findings led directly to surgical treatment of VT by excising 
endocardial tissue proven to be essential for ongoing arrhythmia; 
finally, a cure for VT was possible.38,39 A series of papers followed this 
providing further insights into the behaviour of VT5,40,41 – where circuits 
were, patterns of activation during VT, what accounted for multiple QRS 
morphologies of VT, observations about ‘dead-end’ conduction 
pathways with 2:1 conduction during VT – and led to innovations in 
technique, resulting in improved outcomes.42 This, in turn, paved the 
way for subsequent work in catheter ablation of VT, in which Dr 
Josephson was an active investigator.43 Additional investigations 
involved the aforementioned use of the ECG during VT to localise exit 
sites from circuits,6,7 pace-mapping to corroborate activation 
mapping;44,45 and one of his favourite studies, the effect of endocardial 
tissue resection on electrograms at sites of reentry.46 In this study, a 
multipolar electrode array was positioned on a portion of endocardium 
to which VT had been mapped during the procedure; recordings were 
made during sinus rhythm (and usually also VT); the endocardium was 
then removed by undermining with scissors; and finally, the array was 
placed back in the same position where recordings were repeated 
during sinus rhythm (see Figure 1). This showed that endocardial late 
potentials (recorded after the end of the QRS complex) that correlated 
with mid-diastolic potentials during VT were located on the endocardial 
surface (present prior to resection, absent after), and that the larger 
signals seen during the QRS complex were recorded from deeper 
layers, with their amplitudes decreased by endocardial scar (see Figure 
2). He also participated in studies of VT in the absence of structural 
heart disease47 as well as in the setting of congenital heart disease 
(repaired tetralogy of Fallot, Ebstein anomaly).48,49 One of his last 
battles against VT was in the form of prophylactic catheter ablation of 
VT to try to prevent shocks from implanted defibrillators;50 he always 
believed prevention was a better strategy than rescue (analogy: 
preventing injury by preventing a motor vehicle accident, versus 
rescue by airbag), so this study was a natural fit for him. 
Mechanisms and Tools of Investigation
Dr Josephson was known for his earnest search for a more thorough 
understanding of the mechanisms of arrhythmias, strongly believing 
that correct therapy depended on knowing the correct diagnosis. 
While this seems self-evident, some electrophysiologists still perform 
catheter ablation procedures based on a presumption of a diagnosis 
and mechanism (reentry versus automaticity, for instance), rather than 
taking the extra few seconds or minutes needed to prove the case. A 
long and ultimately unsuccessful procedure can result from a strategy 
of presumption, if incorrect. Dr Josephson penned two perspective 
papers entitled ‘Electrophysiology at a Crossroads’51,52 that set forth 
his reservations about how EP practices had evolved from mechanism- 
and evidence-based care to what was expedient and economically 
driven; these are required reading in many training programmes. 
Dr Josephson’s research into mechanisms of arrhythmias was spread 
throughout his career, starting with a publication on the effects of 
lidocaine in man.53 A few years later, the previously-mentioned work on 
mechanisms of VT appeared as the first of many regarding this 
arrhythmia. Following this were papers describing continuous electrical 
activity during VT;54 the mechanism of ventricular fibrillation;55 structure 
and ultrastructure of surgically-removed specimens from VT patients;56 
and the meaning of endocardial late potentials.57 A series of 
monumental papers on resetting and entrainment of arrhythmias 
began in 198558 and continued for a decade thereafter, including 
resetting response patterns;59,60 resetting in the presence of fusion;61 
comparing results of single-beat resetting versus entrainment;62 
predictability of overdrive pacing to terminate VT;63 and investigation as 
to whether functional or fixed lines of conduction block are present in 
VT.64 The lessons learned from these studies provide substantial help 
in some cases of complex reentry, which are increasingly encountered 
after ablation of AF. Dr Josephson provided a lucid explanation of the 
mechanism of the rare but important disorder known as paroxysmal 
AV block.65 He also contributed to the development of the first 
electroanatomical mapping system.66
Dr Josephson participated in investigations into drug therapy of 
arrhythmias and the adverse effects of these drugs; cardiovascular 
genetics; animal models of arrhythmias; heart failure; valvular heart 
disease; device-based therapy of atrial and ventricular arrhythmias; 
clinical trials in arrhythmia therapy; and healthcare economics. 
Conclusion 
The panoply of contributions by Dr Josephson to our understanding of 
cardiac arrhythmias is far too broad to recount in a short paper. Even 
in failing health in his last two years here, he continued to develop new 
ideas about ways to investigate arrhythmias. His contributions to the 
field are large, both in number and impact; practically every procedure 
that a practicing electrophysiologist does on any given day has been 
influenced by Dr Josephson’s work. These accomplishments were of 
course important to him; far more important were his relationships 
with his family, colleagues and trainees. Ever the advocate and friend, 
he never saw himself as too important or busy to help someone 
understand a difficult point, or offer patient care or career advice when 
asked. A good clinical investigator does good work; an exceptional 
investigator inspires those with whom he works to launch out onto 
their own investigative paths. Dr Josephson was clearly among the 
exceptional. Thus it is that, through his students – who he taught how 
to think and ask questions – his work continues.
Lastly, although Dr Josephson made many new discoveries and 
devised new therapies in his investigative career, some of the 
conclusions he made from these studies turned out to be less than 
completely correct; he was big enough to own up to these and 
criticise his own prior work. A pioneer in any field, like an explorer in 
new territory, occasionally goes down a seemingly promising path that 
eventually leads nowhere. Far more often than not, however, 
Dr Josephson led us down a path of new discovery and we find, in 
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